These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1153 related items for PubMed ID: 6386284

  • 21. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG.
    Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258
    [Abstract] [Full Text] [Related]

  • 22. Lyndiol (1 mg)--evaluation of a new low dose oral contraceptive.
    Banerjee SK.
    Antiseptic; 1977 Sep; 74(9):531-3. PubMed ID: 12281247
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Prescription contraceptives: countering the risks.
    Ruggiero RJ.
    Am Pharm; 1985 Sep; NS25(9):32-7. PubMed ID: 4050670
    [Abstract] [Full Text] [Related]

  • 25. An update on the pill.
    Initiatives Popul; 1983 Sep; 7(3):2-15. PubMed ID: 12339841
    [Abstract] [Full Text] [Related]

  • 26. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
    United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices.
    Netw Res Triangle Park N C; 1986 Sep; 7(4):1-5. PubMed ID: 12341093
    [Abstract] [Full Text] [Related]

  • 27. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 28. [Hormonal contraception using estroprogestins].
    Grio R, Piacentino R, Cellura A, Caccuri D, Zaccheo F, Baccarini G, Marchino GL, Borgarino S, Fuda G.
    Minerva Ginecol; 1990 Mar; 42(3):49-53. PubMed ID: 2187166
    [Abstract] [Full Text] [Related]

  • 29. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U, Dubois M.
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Oral contraceptives.
    Maclennan AH.
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Combined oral contraceptives: acceptability and effective use.
    Kubba A, Guillebaud J.
    Br Med Bull; 1993 Jan; 49(1):140-57. PubMed ID: 8324604
    [Abstract] [Full Text] [Related]

  • 35. Statement on steroidal oral contraceptives.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP.
    IPPF Med Bull; 1981 Dec; 15(6):3-5. PubMed ID: 12263973
    [Abstract] [Full Text] [Related]

  • 36. [Oral contraception and its beneficial gynecological effects].
    Belaisch J, Hommais-loufrani B.
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [Abstract] [Full Text] [Related]

  • 37. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
    Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
    [Abstract] [Full Text] [Related]

  • 38. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance.
    Lebrun CM.
    Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042
    [Abstract] [Full Text] [Related]

  • 39. Combined oral contraception.
    Miller C, Murtagh J.
    Aust Fam Physician; 1992 Dec; 21(12):1787-8. PubMed ID: 1476509
    [Abstract] [Full Text] [Related]

  • 40. Oral steroidal contraception: scientific basis and recent development.
    Sinnathuray TA.
    Malays J Reprod Health; 1988 Dec; 6(2):70-82. PubMed ID: 12342171
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 58.